Literature DB >> 1671768

The codon 408 mutation associated with haplotype 2 is predominant in Polish families with phenylketonuria.

J Jaruzelska1, K F Henriksen, F Güttler, O Riess, K Borski, N Blin, R Slomski.   

Abstract

The incidence of phenylketonuria (PKU) in the western part of Poland is 1 in 5000 live births. Restriction fragment length polymorphism (RFLP) haplotypes at the phenylalanine hydroxylase locus have been analysed in 46 Polish families with PKU. Among 43 fully-informative families 16 RFLP haplotypes were identified. Haplotype 2 is the most frequently (62%) associated with Polish PKU alleles, and the codon 408 mutation is in complete linkage disequilibrium with this haplotype in Poland. This finding is in agreement with observations in other eastern European countries (German Democratic Republic, Czechoslovakia, and Hungary) and in contrast to the genotype distribution observed in western European countries. The present observation suggests the spread of classical PKU, due to the codon 408 mutation associated with haplotype 2, from east to west in European populations. Perhaps more important for genetic counselling, 62% of all PKU chromosomes in the Polish population can now be detected using only one mutant-specific oligonucleotide probe.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671768     DOI: 10.1007/bf00202402

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS.

Authors:  R GUTHRIE; A SUSI
Journal:  Pediatrics       Date:  1963-09       Impact factor: 7.124

2.  Molecular genetics of phenylketonuria in Orientals: linkage disequilibrium between a termination mutation and haplotype 4 of the phenylalanine hydroxylase gene.

Authors:  T Wang; Y Okano; R Eisensmith; S Z Huang; Y T Zeng; W H Lo; S L Woo
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

3.  Collation of RFLP haplotypes at the human phenylalanine hydroxylase (PAH) locus.

Authors:  S L Woo
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

4.  Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase.

Authors:  S C Kwok; F D Ledley; A G DiLella; K J Robson; S L Woo
Journal:  Biochemistry       Date:  1985-01-29       Impact factor: 3.162

5.  Linkage disequilibrium between mutation and RFLP haplotype at the phenylalanine hydroxylase locus in the German population.

Authors:  U Lichter-Konecki; M Schlotter; D S Konecki; S Labeit; S L Woo; F K Trefz
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

6.  Polymorphic DNA haplotypes at the phenylalanine hydroxylase (PAH) locus in European families with phenylketonuria (PKU).

Authors:  S P Daiger; R Chakraborty; L Reed; G Fekete; D Schuler; G Berenssi; I Nasz; R Brdicka; J Kamarýt; A Pijácková
Journal:  Am J Hum Genet       Date:  1989-08       Impact factor: 11.025

7.  An amino-acid substitution involved in phenylketonuria is in linkage disequilibrium with DNA haplotype 2.

Authors:  A G DiLella; J Marvit; K Brayton; S L Woo
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

8.  Polymorphic DNA haplotypes at the human phenylalanine hydroxylase locus and their relationship with phenylketonuria.

Authors:  R Chakraborty; A S Lidsky; S P Daiger; F Güttler; S Sullivan; A G Dilella; S L Woo
Journal:  Hum Genet       Date:  1987-05       Impact factor: 4.132

9.  Screening for phenylketonuria mutations by DNA amplification with the polymerase chain reaction.

Authors:  A G DiLella; W M Huang; S L Woo
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

10.  Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria.

Authors:  S L Woo; A S Lidsky; F Güttler; T Chandra; K J Robson
Journal:  Nature       Date:  1983 Nov 10-16       Impact factor: 49.962

View more
  8 in total

Review 1.  The phenylketonuria locus: current knowledge about alleles and mutations of the phenylalanine hydroxylase gene in various populations.

Authors:  D S Konecki; U Lichter-Konecki
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

2.  Haplotypes and linkage disequilibrium at the phenylalanine hydroxylase locus, PAH, in a global representation of populations.

Authors:  J R Kidd; A J Pakstis; H Zhao; R B Lu; F E Okonofua; A Odunsi; E Grigorenko; B B Tamir; J Friedlaender; L O Schulz; J Parnas; K K Kidd
Journal:  Am J Hum Genet       Date:  2000-04-27       Impact factor: 11.025

3.  Time and space clusters of the French-Canadian M1V phenylketonuria mutation in France.

Authors:  S Lyonnet; D Melle; M de Braekeleer; R Laframboise; F Rey; S W John; M Berthelon; J Berthelot; H Journel; B Le Marec
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

4.  Haplotype distribution at the phenylalanine hydroxylase locus in PKU families from the Moravian area of Czechoslovakia.

Authors:  L Kozák; D Dvoráková; A Pijácková; J Kamarýt
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

5.  Haplotype distribution and mutations at the PAH locus in Croatia.

Authors:  I Barić; D Mardesić; G Gjurić; V Sarnavka; B Göbel-Schreiner; U Lichter-Konecki; D S Konecki; F K Trefz
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

6.  The origin of Eastern European Jews revealed by autosomal, sex chromosomal and mtDNA polymorphisms.

Authors:  Avshalom Zoossmann-Diskin
Journal:  Biol Direct       Date:  2010-10-06       Impact factor: 4.540

7.  Genetic background of clinical homogeneity of phenylketonuria in Poland.

Authors:  J Jaruzelska; R Matuszak; S Lyonnet; F Rey; J Rey; J Filipowicz; K Borski; A Munnich
Journal:  J Med Genet       Date:  1993-03       Impact factor: 6.318

Review 8.  Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria.

Authors: 
Journal:  BMJ       Date:  1993-01-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.